Near universal RT-PCR testing at the end of the Moderna trial showed no significant difference between groups
Executive summary The Moderna COVE trial paper published in 2021 in NEJM claimed 93.2% efficacy in preventing illness with only 55 cases in the vaccine group and 744 in the placebo group. But if you look beyond the abstract, you’ll find something very significant that they “forgot” to mention in the abstract. At the end […]
Discuss on Nostr!
Nostr Note ID note126h28w6tkqsh7xrk0n8n5axmy7aps97j98ujs99mq0e96uf8mnhs44nhzs Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send cryptocurrency to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Send altcoins or fiat:
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.